Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases
暂无分享,去创建一个
K. Perry | A. Folpe | F. Mertens | A. Perez-Atayde | A. Al-Ibraheemi | Jakob Hofvander | Elsa Arbajian | L. Magnusson | Jenny Nilsson | E. Arbajian | J. Nilsson
[1] M. Sun,et al. [Lipofibromatosis: a clinicopathological analysis of eight cases]. , 2018, Zhonghua bing li xue za zhi = Chinese journal of pathology.
[2] P. Pal,et al. ROS1-1 , 2017, Journal of Clinical Pathology.
[3] M. Lim,et al. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] S. Cull-Candy,et al. Structural and Functional Architecture of AMPA-Type Glutamate Receptors and Their Auxiliary Proteins , 2017, Neuron.
[5] J. Custódio,et al. Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box? , 2017, Cancer Chemotherapy and Pharmacology.
[6] A. Folpe,et al. Fibrous hamartoma of infancy: a clinicopathologic study of 145 cases, including 2 with sarcomatous features , 2017, Modern Pathology.
[7] Jason Y. Park,et al. EGFR Exon 20 Insertion/Duplication Mutations Characterize Fibrous Hamartoma of Infancy , 2016, The American journal of surgical pathology.
[8] Narasimhan P. Agaram,et al. Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors , 2016, The American journal of surgical pathology.
[9] C. Strahlendorf,et al. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors , 2016, The American journal of surgical pathology.
[10] Y. Oda,et al. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours , 2016, Histopathology.
[11] C. Antonescu,et al. Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes , 2016, Genes, chromosomes & cancer.
[12] F. Mertens,et al. FN1–EGF gene fusions are recurrent in calcifying aponeurotic fibroma , 2016, The Journal of pathology.
[13] C. Antonescu,et al. Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement , 2015, The American journal of surgical pathology.
[14] D. Gisselsson,et al. Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing , 2015, Laboratory Investigation.
[15] M. Caraglia,et al. PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy , 2015, Endocrine.
[16] O. Kallioniemi,et al. FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.
[17] Nicolas Stransky,et al. The landscape of kinase fusions in cancer , 2014, Nature Communications.
[18] P. Stephens,et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. , 2014, Cancer discovery.
[19] J. Dormans,et al. Lipofibromatosis: An Institutional and Literature Review of an Uncommon Entity , 2014, Pediatric dermatology.
[20] T. Fioretos,et al. A novel SERPINE1–FOSB fusion gene results in transcriptional up‐regulation of FOSB in pseudomyogenic haemangioendothelioma , 2014, The Journal of pathology.
[21] A. D. Dei Tos,et al. Lipofibromatosis: magnetic resonance imaging features and pathological correlation in three cases , 2014, Skeletal Radiology.
[22] K. Tamama,et al. Early Growth Response Genes Signaling Supports Strong Paracrine Capability of Mesenchymal Stem Cells , 2012, Stem cells international.
[23] B. Gharibi,et al. Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal , 2012, Journal of cellular and molecular medicine.
[24] Christopher A. Maher,et al. ChimeraScan: a tool for identifying chimeric transcription in sequencing data , 2011, Bioinform..
[25] W. Tourtellotte,et al. Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy. , 2011, Matrix biology : journal of the International Society for Matrix Biology.
[26] Yosef Yarden,et al. Feedback regulation of EGFR signalling: decision making by early and delayed loops , 2011, Nature Reviews Molecular Cell Biology.
[27] Geraldo Pereira Jotz,et al. Glutamate Promotes Cell Growth by EGFR Signaling on U-87MG Human Glioblastoma Cell Line , 2010, Pathology & Oncology Research.
[28] Jeffrey A. Engelman,et al. Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.
[29] E. Zambrano,et al. Chromosomal rearrangements in lipofibromatosis. , 2007, Cancer genetics and cytogenetics.
[30] Y. Yoshida,et al. Ca2+-Permeable AMPA Receptors Regulate Growth of Human Glioblastoma via Akt Activation , 2007, The Journal of Neuroscience.
[31] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[32] M. Miettinen,et al. A Clinicopathologic Study of 45 Pediatric Soft Tissue Tumors With an Admixture of Adipose Tissue and Fibroblastic Elements, and a Proposal for Classification as Lipofibromatosis , 2000, The American journal of surgical pathology.
[33] P. D. Dal Cin,et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.
[34] C. Griffin,et al. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. , 1999, Cancer research.
[35] M. Miettinen,et al. Calcifying aponeurotic fibroma: a clinicopathologic study of 22 cases arising in uncommon sites. , 1998, Human pathology.
[36] Stout Ap. The fibromatoses and fibrosarcoma. , 1951 .
[37] J. Kobos,et al. Lipofibromatosis presenting as a neck mass in eight-years old boy--a case report. , 2008, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[38] R. Brekken,et al. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. , 2001, Matrix biology : journal of the International Society for Matrix Biology.